These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21387318)

  • 1. Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release.
    Vialpando M; Aerts A; Persoons J; Martens J; Van Den Mooter G
    J Pharm Sci; 2011 Aug; 100(8):3411-3420. PubMed ID: 21387318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen.
    Vialpando M; Backhuijs F; Martens JA; Van den Mooter G
    Eur J Pharm Biopharm; 2012 May; 81(1):190-8. PubMed ID: 22306694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
    Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
    J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
    Quan GL; Chen B; Wang ZH; Wu H; Huang XT; Wu LN; Wu CB
    Yao Xue Xue Bao; 2012 Feb; 47(2):239-43. PubMed ID: 22512038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
    Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica.
    Mellaerts R; Mols R; Jammaer JA; Aerts CA; Annaert P; Van Humbeeck J; Van den Mooter G; Augustijns P; Martens JA
    Eur J Pharm Biopharm; 2008 May; 69(1):223-30. PubMed ID: 18164930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agglomeration of mesoporous silica by melt and steam granulation. Part I: a comparison between disordered and ordered mesoporous silica.
    Vialpando M; Albertini B; Passerini N; Bergers D; Rombaut P; Martens JA; Van Den Mooter G
    J Pharm Sci; 2013 Nov; 102(11):3966-77. PubMed ID: 23946143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property.
    Zhang Y; Jiang T; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2010 Sep; 76(1):17-23. PubMed ID: 20685333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs.
    Vialpando M; Martens JA; Van den Mooter G
    Ther Deliv; 2011 Aug; 2(8):1079-91. PubMed ID: 22833866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ordered mesoporous silica induces pH-independent supersaturation of the basic low solubility compound itraconazole resulting in enhanced transepithelial transport.
    Mellaerts R; Mols R; Kayaert P; Annaert P; Van Humbeeck J; Van den Mooter G; Martens JA; Augustijns P
    Int J Pharm; 2008 Jun; 357(1-2):169-79. PubMed ID: 18325700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.